Strata Skin Sciences
SSKN
SSKN was delisted on the 18th of February, 2026.
15 hedge funds and large institutions have $1.1M invested in Strata Skin Sciences in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
4% more capital invested
Capital invested by funds: $1.05M → $1.1M (+$46.6K)
0.21% less ownership
Funds ownership: 2.39% → 2.18% (-0.21%)
12% less funds holding
Funds holding: 17 → 15 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$217K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$172K |
| 3 |
Renaissance Technologies
New York
|
+$59.3K |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$51.8K |
| 5 |
VF
Virtu Financial
New York
|
+$17.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$65K |
| 2 |
AAM
Azzad Asset Management
Falls Church,
Virginia
|
-$47.4K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$28K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.71K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
-$1K |
SSKN Hedge Fund Activity: Q4 2017 in Review
15 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Strata Skin Sciences (SSKN) for Q4 2017, worth a combined $1.1M — up 4.4% from $1.05M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SSKN and 3 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 7 added.
The largest buyer was Broadfin Capital, adding an estimated $217K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $65K sold.
- 15 institutional investors held Strata Skin Sciences (SSKN) as of Q4 2017, down from 17 in Q3 2017.
- Funds reported $1.1M of Strata Skin Sciences stock for Q4 2017, up 4.4% quarter-over-quarter.
- 3 funds opened new Strata Skin Sciences positions in Q4 2017 and 5 closed out, a net change of -2 holders.
- The largest Strata Skin Sciences buyer in Q4 2017 was Broadfin Capital, an estimated $217K added.
- The largest Strata Skin Sciences seller in Q4 2017 was Bank of New York Mellon, an estimated $65K sold.
Based on aggregated 13F filings for Q4 2017.